Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Cancer Research

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11410498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGFp Signals through a Heteromeric Protein Kinase Receptor Complex

  2003cited by this paper
• Inhibition of Growth by Transforming Growth Factor-@ following Fusion of Two Nonresponsive Human Carcinoma Cell Lines

  2001cited by this paper
• The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck

  2000cited by this paper
• Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.

  2000cited by this paper
• Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging

  2000cited by this paper
• The Smad pathway.

  2000cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity.

  1999cited by this paper
• Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis

  1999cited by this paper
• Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.

  1999cited by this paper
• Transforming growth factor β receptors in verrucous and squamous cell carcinoma

  1999cited by this paper
• Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.

  1999cited by this paper
• Expression of Transforming Growth Factor β Type II Receptors in Head and Neck Squamous Cell Carcinoma

  1999cited by this paper
• Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma.

  1999cited by this paper
• Expression and mutational analysis of the MADR2/smad2 gene in human prostate cancer

  1999cited by this paper
• Frequent aberration of the transforming growth factor‐β receptor II gene in cell lines but no apparent mutation in pre‐invasive and invasive carcinomas of the uterine cervix

  1999cited by this paper
• The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

  1999cited by this paper
• Expression of TGF-beta related Smad proteins in human epithelial skin tumors.

  1999cited by this paper
• Mutation analysis of the Smad3 gene in human ovarian cancers.

  1999cited by this paper
• Transforming growth factor beta receptors in verrucous and squamous cell carcinoma.

  1999cited by this paper
• The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.

  1999cited by this paper
• Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer.

  1999cited by this paper
• Microsatellite alterations and p53, TGFβRII, IGFIIR and BAX mutations in sporadic non‐small‐cell lung cancer

  1998cited by this paper
• Mads and Smads in TGFβ signalling

  1998cited by this paper
• Induction of Smad6 mRNA by bone morphogenetic proteins.

  1998cited by this paper
• Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway.

  1998cited by this paper
• Mads and Smads in TGF beta signalling.

  1998cited by this paper
• Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.

  1998cited by this paper
• Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members.

  1998cited by this paper
• Tumor suppressing pathways.

  1998cited by this paper
• Smad6 functions as an intracellular antagonist of some TGF‐β family members during Xenopus embryogenesis

  1998cited by this paper
• Genomic alterations associated with malignancy in head and neck cancer

  1998cited by this paper
• Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer*

  1998cited by this paper
• Transforming growth factor beta1 induces nuclear export of inhibitory Smad7.

  1998cited by this paper
• Characterization of theMADH2/Smad2Gene, a HumanMadHomolog Responsible for the Transforming Growth Factor-β and Activin Signal Transduction Pathway

  1998cited by this paper
• Frequency of Smad gene mutations in human cancers.

  1997cited by this paper
• TGF-beta receptors and signal transduction.

  1997cited by this paper
• Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23.

  1997cited by this paper
• Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles.

  1997cited by this paper
• Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.

  1997cited by this paper
• Evidence that loss of chromosome 18q is associated with tumor progression.

  1997cited by this paper
• Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck.

  1997cited by this paper
• Prognostic Indicators for Squamous Cell Carcinoma of the Oral Cavity: A Clinicopathologic Correlation

  1997cited by this paper
• Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• TGF-β receptors and signal transduction

  1996cited by this paper
• Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.

  1996cited by this paper
• p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas

  1996cited by this paper
• MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

  1996influential reference
• Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization

  1996cited by this paper
• Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.

  1995cited by this paper
• Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

  1995cited by this paper
• B7-1 expression by a non-antigen presenting cell-derived tumor.

  1995cited by this paper
• Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.

  1994cited by this paper
• p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx

  1994cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

  1994cited by this paper
• Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region

  1994cited by this paper
• Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.

  1994cited by this paper
• Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

  1994cited by this paper
• Mechanism of activation of the TGF-β receptor

  1994cited by this paper
• Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.

  1994cited by this paper
• Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells

  1994cited by this paper
• Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.

  1993cited by this paper
• The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck.

  1993cited by this paper
• Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses.

  1992cited by this paper
• TGF beta signals through a heteromeric protein kinase receptor complex.

  1992cited by this paper
• Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.

  1992cited by this paper
• Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Effects of bombesin on growth of human small cell lung carcinoma in vivo.

  1988cited by this paper
• The manual for the staging of cancer.

  1977cited by this paper
• Genetic changes in the transforming growth factor f8 (TGF-fi) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-,

  year unknowncited by this paper
• Transforming Growth Factor (cid:98) Receptors in Verrucous and Squamous Cell Carcinoma

  year unknowncited by this paper

• Aberrations in SMAD family of genes among HNSCC patients

  2021cites this paper
• The Activation Status of the TGF-β Transducer Smad2 Is Associated with a Reduced Survival in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis

  2019cites this paper
• Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells

  2019cites this paper
• Transforming Growth Factor Beta (TGF-β) Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC)

  2018cites this paper
• Paradoxical roles of TGF-&bgr; signaling in suppressing and promoting squamous cell carcinoma

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer.

  2016cites this paper
• HNSCC Biomarkers Derived from Key Processes of Cancerogenesis

  2016cites this paper
• Tissue Characterization and Cancer Detection Based on Bioimpedance Spectroscopy

  2015cites this paper
• Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm

  2015cites this paper
• TGFβ Regulates EMT in Head and Neck Cancer

  2014cites this paper
• Possible association between TGF‐β1 polymorphism and oral cancer

  2013influential citation
• Differential Gene Expression Patterns in HPV-Positive and HPV-Negative Oropharyngeal Carcinomas

  2013cites this paper
• A novel gain-of-function mutation of TGF-β receptor II promotes cancer progression via delayed receptor internalization in oral squamous cell carcinoma.

  2012cites this paper
• Two sides of the story? Smad4 loss in pancreatic cancer versus head‐and‐neck cancer

  2012cites this paper
• Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation.

  2012cites this paper
• Alterations of Transforming Growth Factor-β Signaling in Squamous Cell Carcinomas

  2011cites this paper
• Roles of TGFβ signaling Smads in squamous cell carcinoma

  2011cites this paper
• Aberrant expression in multiple components of the transforming growth factor-β1-induced Smad signaling pathway during 7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch squamous-cell carcinogenesis.

  2011cites this paper
• MicroRNA regulation of tumor-initiating-cells in metastasis and chemoresistance

  2011cites this paper
• Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients

  2010cites this paper
• TGFβ signaling in head and neck squamous cell carcinoma

  2010cites this paper
• The effect of transforming growth factor-β1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-β/Smad pathway

  2010cites this paper
• Growth inhibition induced by transforming growth factor-β1 in human oral squamous cell carcinoma

  2009cites this paper
• TGFβ signaling in head and neck cancer development and metastases

  2009cites this paper
• Smad4: gatekeeper gene in head and neck squamous cell carcinoma.

  2009cites this paper
• Molecular mechanisms of head and neck cancer

  2008cites this paper
• Role of Transforming Growth Factor-β in the Pathogenesis of Human Head and Neck Squamous Cell Carcinoma

  2008cites this paper
• Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.

  2008cites this paper
• Loss of expression of TGF-β1, TβRI, and TβRII correlates with differentiation in human oral squamous cell carcinomas

  2008cites this paper
• Role of Smad4 loss in head and neck squamous cell carcinoma

  2008cites this paper
• Increased expression of TGF-beta/Smad proteins in basal cell carcinoma.

  2007cites this paper
• INCREASEDEXPRESSIONOFTGF-β/SMADPROTEINSIN BASALCELLCARCINOMA

  2007cites this paper
• Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.

  2007cites this paper
• Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma.

  2006cites this paper
• Lack of activated Smad2 in transforming growth factor‐β signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma

  2006cites this paper
• BASIC SCIENCE REVIEW

  2006cites this paper
• Motility in Head and Neck Carcinoma

  2006cites this paper
• Cell Motility in Cancer Invasion and Metastasis

  2006cites this paper
• Aberrant expression of Smad 4 , a TGF-β signaling molecule , in oral squamous cell carcinoma

  2006cites this paper
• Farnesyl Protein Transferase Inhibitors: Medicinal Chemistry, Molecular Mechanisms,and Progress in the Clinic

  2006cites this paper
• Transforming Growth Factor-B ,S mads, and Cancer

  2005cites this paper
• Smad signal and TGFβ induced apoptosis in human lymphoma cells

  2005cites this paper
• Differences in Smad4 Expression in Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Squamous Cell Carcinoma

  2005cites this paper
• Transforming Growth Factor-β, Smads, and Cancer

  2005cites this paper
• Transforming growth factor-beta, Smads, and cancer.

  2005cites this paper
• Smad signal and TGFbeta induced apoptosis in human lymphoma cells.

  2005cites this paper
• Attenuated type II TGF‐β receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination

  2004cites this paper
• Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta

  2004cites this paper
• Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.

  2004cites this paper
• The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II).

  2004cites this paper
• The Roles of Smad2 and Smad3 in the Development of Chemically Induced Skin Tumors in Mice

  2004cites this paper
• Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-β*

  2004cites this paper
• Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis.

  2004cites this paper
• Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF‐β 1

  2004cites this paper
• Role of the Inhibin/Activin System and Luteinizing Hormone in Adrenocortical Tumorigenesis

  2004cites this paper
• Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.

  2003cites this paper
• The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.

  2003cites this paper
• Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice

  2003cites this paper
• Reduction in Smad 2 / 3 Signaling Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines

  2003cites this paper
• Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis.

  2003cites this paper
• but Suppresses Metastasis of Breast Cancer Cell Lines Reduction in Smad 2 / 3 Signaling Enhances Tumorigenesis

  2003cites this paper
• Connective tissue disease coincident with nasopharyngeal carcinoma: two sporadic cases in a Western population.

  2003cites this paper
• Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.

  2003cites this paper
• Binding of TGF-β1 latency-associated peptide (LAP) to αvβ6 integrin modulates behaviour of squamous carcinoma cells

  2002cites this paper
• High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.

  2002cites this paper
• Existen riesgos al utilizar los concentrados de Plasma Rico en Plaquetas (PRP) de uso ambulatorio

  2002cites this paper
• Suppression of rho B expression in invasive carcinoma from head and neck cancer patients.

  2002cites this paper
• Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase.

  2002cites this paper
• Decreased Smad4 expression in the transforming growth factor‐β signaling pathway during progression of esophageal squamous cell carcinoma

  2002cites this paper
• Significance of tumor-cell receptors in human cancer.

  2002cites this paper
• Induction of prostate apoptosis by α1-adrenoceptor antagonists: mechanistic significance of the quinazoline component

  2002cites this paper
• High-Level Expression of the Smad Ubiquitin Ligase Smurf 2 Correlates with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma 1

  2002cites this paper
• II ) in Epithelial Malignancy and its Relevance to the Pathogenesis of Oral Cancer ( Part β The Role of TGF -

  year unknowncites this paper